A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer

Annals of Surgical Oncology

Volumn 17, Issue 1, 2010, Pages 194-205

  Morganti, Alessio G ^a   Massaccesi, Mariangela ^a   La Torre, Giuseppe ^b   Caravatta, Luciana ^a   Piscopo, Adele ^a   Tambaro, Rosa ^a   Sofo, Luigi ^a   Sallustio, Giuseppina ^a   Ingrosso, Marcello ^a   MacChia, Gabriella ^a   Deodato, Francesco ^a   Picardi, Vincenzo ^a   Ippolito, Edy ^a   Cellini, Numa ^c   Valentini, Vincenzo ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CISPLATIN; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; OXALIPLATIN; PACLITAXEL; STREPTOZOCIN;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS RESECTION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SURVIVAL TIME; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT RESPONSE;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; NEOADJUVANT THERAPY; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 74649084777     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0762-4     Document Type: Article

References (65)

1. A Jemal R Siegel E Ward T Murray J Xu C Smigal MJ Thun 2006 Cancer statistics, 2006 CA Cancer J Clin 2006 56 106 130 10.3322/canjclin.56.2.106
2. RJ Black F Bray J Ferlay DM Parkin 1997 Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990 Eur J Cancer 33 1075 1107 10.1016/S0959-8049(96)00492-3 1:STN:280:DyaK1c%2Fit1SmtA%3D%3D 9376190 (Pubitemid 27310783)
3. M Wagner C Redaelli M Lietz CA Seiler H Friess MW Büchler 2004 Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 586 594 10.1002/bjs.4484 1:STN:280:DC%2BD2c3it1ansA%3D%3D 15122610 (Pubitemid 38624667)
4. SP Cleary R Gryfe M Guindi P Greig L Smith R Mackenzie S Strasberg, et al. 2004 Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors J Am Coll Surg 198 722 731 10.1016/j.jamcollsurg.2004. 01.008 15110805 (Pubitemid 38542900)
5. KC Conlon DS Klimstra MF Brennan 1996 Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors Ann Surg 223 273 279 10.1097/00000658-199603000-00007 1:STN:280:DyaK287pvFSgsQ%3D%3D 8604907 (Pubitemid 26086718)
6. C Sperti C Pasquali A Piccoli S Pedrazzoli 1996 Survival after resection for ductal adenocarcinoma of the pancreas Br J Surg 83 625 631 10.1002/bjs.1800830512 1:STN:280:DyaK283ps1agug%3D%3D 8689203 (Pubitemid 26163547)
7. TA Sohn CJ Yeo JL Cameron L Koniaris S Kaushal RA Abrams PK Sauter, et al. 2000 Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 567 579 10.1016/S1091-255X(00)80105-5 1:STN:280:DC%2BD3Mzlt1yqtA%3D%3D 11307091
8. CJ Yeo TA Sohn JL Cameron RH Hruban KD Lillemoe HA Pitt 1998 Periampullary adenocarcinoma: analysis of 5-year survivors Ann Surg 227 821 831 10.1097/00000658-199806000-00005 1:STN:280:DyaK1c3pvFKmug%3D%3D 9637545 (Pubitemid 29119529)
9. A Jemal T Murray E Ward A Samuels RC Tiwari A Ghafoor EJ Feuer, et al. 2005 Cancer statistics CA Cancer J Clin 2005 55 10 30 10.3322/canjclin.55.1.10
10. Gastrointestinal Tumor Study Group 1988 Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 751 755 10.1093/jnci/80.10.751
11. Gastrointestinal Tumor Study Group 1979 A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma Ann Surg 189 205 208
12. B Chauffert F Mornex F Bonnetain P Rougier C Mariette O Bouché JF Bosset, et al. 2008 Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study Ann Oncol 19 1592 1599 10.1093/annonc/mdn281 1:STN:280: DC%2BD1crivFChsQ%3D%3D 18467316
13. PJ Loehrer ME Powell HR Cardenes L Wagner JM Brell RK Ramanathan CH Crane, et al. 2008 A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201 [abstract] J Clin Oncol 26 Suppl 15 4506a
14. HJ Wanebo AS Glicksman MP Vezeridis J Clark L Tibbetts RJ Koness A Levy 2000 Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer Arch Surg 135 81 87 10.1001/archsurg.135.1.81 1:STN:280:DC%2BD3c7gtVejug%3D%3D 10636353
15. H Snady H Bruckner A Cooperman J Paradiso L Kiefer 2000 Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial Cancer 89 314 327 10.1002/1097-0142(20000715)89:2<314::AID-CNCR16>3.0. CO;2-V 1:STN:280:DC%2BD3czptlSjtg%3D%3D 10918161 (Pubitemid 30489879)
16. JB Ammori LM Colletti MM Zalupski FE Eckhauser JK Greenson J Dimick TS Lawrence CJ McGinn 2003 Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas J Gastrointest Surg 7 766 772 10.1016/S1091-255X(03)00113-6 13129554 (Pubitemid 37103131)
17. J Aristu R Cañón F Pardo R Martínez-Monge S Martin-Algarra J Manuel Ordoñez E Villafranca, et al. 2003 Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer Am J Clin Oncol (CCT) 26 30 36 10.1097/00000421-200302000-00007 (Pubitemid 36205894)
18. A Sa Cunha A Rault C Laurent X Adhoute V Vendrely G Bé llannée R Brunet, et al. 2005 Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas J Am Coll Surg 201 359 365 10.1016/j.jamcollsurg.2005.04.008 16125068 (Pubitemid 41206773)
19. X Adhoute D Smith V Vendrely A Rault A Sa Cunha JL Legoux G Belleannée, et al. 2006 Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapy Gastroenterol Clin Biol 30 224 230 16565654
20. RR White DS Tyler 2004 Neoadjuvant therapy for pancreatic cancer: the Duke experience Surg Oncol Clin North Am 13 675 684 10.1016/j.soc.2004.06.001 (Pubitemid 39209347)
21. GV Kornek A Schratter-Sehn A Marczell D Depisch J Karner G Krauss K Haider, et al. 2000 Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin Br J Cancer 82 98 103 10.1054/bjoc.1999.0884 1:CAS:528: DC%2BD3cXltFWlug%3D%3D 10638974
22. HJ Kim K Czischke MF Brennan KC Conlon 2002 Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg 6 763 769 10.1016/S1091-255X(02)00017-3 12399067 (Pubitemid 40433496)
23. CH Crane JL Abbruzzese DB Evans RA Wolff MT Ballo M Delclos L Milas, et al. 2002 Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys 52 1293 1302 10.1016/S0360-3016(01)02740-7 1:CAS:528:DC%2BD38XivVSntr0%3D 11955742 (Pubitemid 34302881)
24. FB Zimmermann C Schuhmacher C Lersch B Bernhardt P Pickel JR Siewert M Molls, et al. 2004 Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure Hepatogastroenterology 51 1842 1846 15532839
25. Grading systems and levels of evidence and grades of recommendation. SIGN guideline development handbook: SIGN 50 Available at: http://www.sign.ac.uk/ pdf/sign50.pdf.
26. RR White HI Hurwitz MA Morse C Lee MS Anscher EK Paulson MR Gottfried, et al. 2001 Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas Ann Surg Oncol 8 758 765 10.1007/s10434-001-0758-1 1:STN:280: DC%2BD38%2FkvVygug%3D%3D 11776488
27. TB Brunner GG Grabenbauer S Kastl O Herrmann U Baum R Fietkau P Klein, et al. 2000 Preoperative chemoradiation in locally advanced pancreatic carcinoma: a phase II study Onkologie 23 436 442 10.1159/000027214 11441238
28. R Wilkowski M Thoma R Schauer A Wagner V Heinemann 2004 Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer World J Surg 28 1011 1018 10.1007/s00268-004-7338-z 15573257 (Pubitemid 40109886)
29. R Wilkowski M Thoma C Bruns A Wagner V Heinemann 2006 Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer JOP 7 349 360 16832132
30. G Macchia V Valentini GC Mattiucci G Mantini S Alfieri C Digesù F Deodato 2007 Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma Tumori 93 53 60 1:CAS:528:DC%2BD2sXks1altbo%3D 17455872
31. PA Lind B Isaksson M Almström A Johnsson N Albiin P Byström J Permert 2008 Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma Acta Oncol 47 413 420 10.1080/02841860701592384 1:CAS:528:DC%2BD1cXjtlWhtLY%3D 17882555
32. C Milandri R Polico A Gardini A Passardi A Romeo A Zaccaroni A Rosetti, et al. 2008 Chemoradiotherapy for unresectable locally advanced pancreatic cancer: a pilot study [abstract] J Clin Oncol 26 Suppl 15 15630a
33. JR Delpero O Turrini 2006 Locally advanced pancreatic adenocarcinoma. Chemoradiotherapy, reevaluation and secondary resection Cancer Radiother 10 462 470 16987678
34. R Wilkowski C Stoffregen H-G Rau MM Heiss M Thoma E Dühmke F Langer V Heinemann 2001 Chemoradiation with gemcitabine (G) in primary inoperable pancreatic cancer Proc Am Soc Clin Oncol 20 A2317
35. P Massucco L Capussotti A Magnino E Sperti M Gatti A Muratore E Sgotto, et al. 2006 Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival Ann Surg Oncol 13 1201 1208 10.1245/s10434-006-9032-x 16955382 (Pubitemid 44440421)
36. JL Marti HS Hochster SP Hiotis B Donahue T Ryan E Newman 2008 Phase I/II trial of induction chemotherapy followed by concurrent chemoradiotherapy and surgery for locoregionally advanced pancreatic cancer Ann Surg Oncol. 15 3521 3531 10.1245/s10434-008-0152-3 18830756
37. W Small J Berlin GM Freedman T Lawrence M Talamonti, et al. 2008 Full-dose gemcitabine with concurrent radiation therapy in patient with nonmetastatic pancreatic cancer. A multicenter phase II trial J Clin Oncol 26 942 947 10.1200/JCO.2007.13.9014 1:CAS:528:DC%2BD1cXjtFelt74%3D 18281668
38. MHG Katz PWT Pisters DB Evans CC Sun JE Lee, et al. 2008 Borderline resectable pancreatic cancer: the importance of this emerging stage of disease J Am Coll Surg 206 833 846 10.1016/j.jamcollsurg.2007.12.020 18471707
39. CH Crane LM Ellis JL Abbruzzese, et al. 2006 Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer J Clin Oncol 24 1145 1151 10.1200/JCO.2005.03.6780 1:CAS:528:DC%2BD28XislGgsbk%3D 16505434 (Pubitemid 46638812)
40. T Rich J Harris R Abrams, et al. 2004 Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12 Am J Clin Oncol 27 51 56 10.1097/01.coc.0000046300.88847.BF 1:CAS:528:DC%2BD2cXjtVKlsrw%3D 14758134 (Pubitemid 38176292)
41. Rich T, Myerson R, Harris J, et al. A randomized phase II trial of weekly gemcitabine (G), paclitaxel (P), and external irradiation followed by the farnesyl transferase inhibitor R115777 (NSC#702818) for locally advanced pancreatic cancer (RTOG 0020) [abstract]. Proc Gastrointest Cancers Symp. 2006:A-121.
42. AH Ko JM Quivey AP Venook, et al. 2007 A phase II study of fixed-ose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 68 809 816 1:CAS:528:DC%2BD2sXmtVamt78%3D 17363191
43. CH Crane K Winter W Regine, et al. 2007 A phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer [abstract] Int J Radiat Oncol Biol Phys 67 Suppl 77 136a
44. A Duffy J Kortmansky GK Schwartz, et al. 2008 A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma Ann Oncol 19 86 91 10.1093/annonc/mdm441 1:STN:280:DC%2BD1c%2FgtVakug%3D%3D 17878176
45. JL Martin HA Harvey A Lipton R Martin 1999 Combined chemoradiotherapy for unresectable pancreatic cancer Am J Clin Oncol 22 309 314 10.1097/00000421- 199906000-00021 1:STN:280:DyaK1M3ovFWqsg%3D%3D 10362344
46. H Safran W Cioffi D Iannitti A Mega P Akerman 1998 Paclitaxel and concurrent radiation for locally advanced pancreatic carcinoma Front Biosci 3 204 206
47. H Ishii S Okada K Tokuuye H Nose T Okusaka M Yoshimori H Nagahama, et al. 1997 Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma Cancer 79 1516 1520 10.1002/(SICI)1097-0142(19970415)79:8<1516::AID-CNCR11>3.0.CO;2-0 1:CAS:528:DyaK2sXislamtr8%3D 9118032 (Pubitemid 27154781)
48. RR White EK Paulson KS Freed MT Keogan HI Hurwitz C Lee MA Morse, et al. 2001 Staging of pancreatic cancer before and after neoadjuvant chemoradiation J Gastrointest Surg 5 626 633 10.1016/S1091-255X(01)80105-0 1:STN:280: DC%2BD38zkt1CqsA%3D%3D 12086901 (Pubitemid 33651269)
49. JP Hoffman P O'Dwyer P Agarwal H Salazar N Ahmad 1996 Preoperative chemoradiotherapy for localized pancreatic carcinoma. A perspective Cancer 78 Suppl 3 592 597 1:CAS:528:DyaK28XltVagtLg%3D 8681297
50. CG Lall TJ Howard A Skandarajah JM DeWitt AM Aisen K Sandrasegaran 2007 New concepts in staging and treatment of locally advanced pancreatic head cancer AJR Am J Roentgenol 189 1044 1050 10.2214/AJR.07.2131 17954638 (Pubitemid 350032986)
51. National Comprehensive Cancer Network (NCCN). Pancreatic adenocarcinoma. Practice guidelines in oncology. V. 2008. Fort Washington, PA. Available at http://www.nccn.org/professionals/physician-gls/PDF/pancreatic.pdf.
52. GR Varadhachary EP Tamm JL Abbruzzese, et al. 2006 Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy Ann Surg Oncol 13 1035 1046 10.1245/ASO.2006.08.011 16865597 (Pubitemid 44337962)
53. DSK Lu HA Reber RM Krasny BM Kadell J Sayre 1997 Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT AJR Am J Roentgenol 168 1439 1443 1:STN:280:DyaK2szht1alsQ%3D%3D 9168704
54. JC Wong DS Lu 2008 Staging of pancreatic adenocarcinoma by imaging studies Clin Gastroenterol Hepatol 6 1301 1308 10.1016/j.cgh.2008.09.014 18948228
55. I Esposito J Kleeff F Bergmann C Reiser E Herpel H Friess P Schirmacher MW Büchler 2008 Most pancreatic cancer resections are R1 resections Ann Surg Oncol 15 1651 1660 10.1245/s10434-008-9839-8 18351300
56. CS Verbeke 2008 Resection margins and R1 rates in pancreatic cancer: are we there yet? Histopathology 52 787 796 10.1111/j.1365-2559.2007.02935.x 1:STN:280:DC%2BD1czjtVKnuw%3D%3D 18081813 (Pubitemid 351724902)
57. Van den Broeck A, Sergeant G, Ectors N, Van Steenbergen W, Aerts R, Topal B. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2009 Jan 6. [Epub ahead of print].
58. JH Klinkenbijl J Jeekel T Sahmoud R van Pel ML Couvreur CH Veenhof JP Arnaud, et al. 1999 Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 776 782 10.1097/00000658-199912000-00006 1:STN:280:DC%2BD3c%2FotFKkug%3D%3D 10615932 (Pubitemid 30191812)
59. JP Neoptolemos DD Stocken H Friess C Bassi JA Dunn H Hickey H Beger, et al. 2004 European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 1200 1210 10.1056/NEJMoa032295 1:CAS:528:DC%2BD2cXit12rtr8%3D 15028824 (Pubitemid 38339364)
60. T Kosuge T Kiuchi K Mukai T Kakizoe 2006 Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP). A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer Jpn J Clin Oncol 36 159 165 10.1093/jjco/hyi234 16490736
61. H Oettle S Post P Neuhaus K Gellert J Langrehr K Ridwelski H Schramm, et al. 2007 Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 267 277 10.1001/jama.297.3.267 1:CAS:528: DC%2BD2sXotVCmug%3D%3D 17227978 (Pubitemid 46143304)
62. JP Neoptolemos DD Stocken C Tudur Smith C Bassi P Ghaneh E Owen M Moore, et al. 2009 Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials Br J Cancer 100 246 250 10.1038/sj.bjc.6604838 1:CAS:528:DC%2BD1MXpsVSqug%3D%3D 19127260
63. C Sperti C Pasquali A Piccoli S Pedrazzoli 1997 Recurrence after resection for ductal adenocarcinoma of the pancreas World J Surg 21 195 200 10.1007/s002689900215 1:STN:280:DyaK2s7lt1ensA%3D%3D 8995078 (Pubitemid 27053441)
64. PW Lin YS Shan YJ Lin CJ Hung 2005 Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure Hepatogastroenterology 52 1601 1604 16201125
65. KT Tran HG Smeenk CH van Eijck G Kazemier WC Hop JW Greve OT Terpstra, et al. 2004 Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors Ann Surg 240 738 745 10.1097/01.sla. 0000143248.71964.29 15492552 (Pubitemid 39425763)